Michael Crump - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael Crump

Showing results (161-170 of 183) with videos related to

Pageof 19

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS StudyLaurie H Sehn, Andre Goy, Fritz C Offner, et al.

Blood|August 14, 2020

Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphomaPier Luigi Zinzani, Ian W Flinn, Sam L S Yuen, et al.

Clinical Lymphoma, Myeloma & Leukemia|August 2, 2021

A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic LeukemiaMatthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013

MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphomaRashmi S Goswami, Eshetu G Atenafu, Yali Xuan, et al.

American Journal of Hematology|September 10, 2022

Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphomaTracy Lackraj, Sharon Ben Barouch, Jessie J F Medeiros, et al.

British Journal of Haematology|September 8, 2015

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern eraCatherine S Diefenbach, Hailun Li, Fangxin Hong, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I TrialMartin Hutchings, Franck Morschhauser, Gloria Iacoboni, et al.

British Journal of Haematology|September 13, 2024

A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphomaJohn Kuruvilla, Christopher Rushton, Diego Villa, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014

Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12Michael Crump, John Kuruvilla, Stephen Couban, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant groupDiego Villa, Michael Crump, Tony Panzarella, et al.

Pageof 19

Search research articles

Showing results (161-170 of 183) with videos related to

Sort By:

Pageof 19

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015

Blood|August 14, 2020

Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphomaPier Luigi Zinzani, Ian W Flinn, Sam L S Yuen, et al.

Clinical Lymphoma, Myeloma & Leukemia|August 2, 2021

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013

American Journal of Hematology|September 10, 2022

Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphomaTracy Lackraj, Sharon Ben Barouch, Jessie J F Medeiros, et al.

British Journal of Haematology|September 8, 2015

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern eraCatherine S Diefenbach, Hailun Li, Fangxin Hong, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021

British Journal of Haematology|September 13, 2024

A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphomaJohn Kuruvilla, Christopher Rushton, Diego Villa, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant groupDiego Villa, Michael Crump, Tony Panzarella, et al.

Pageof 19